High-throughput development and characterization of new functional nanobodies for gene regulation and epigenetic control in human cells.

Controlling gene expression and chromatin state via the recruitment of transcriptional effector proteins to specific genetic loci has advanced the potential of mammalian synthetic biology, but is still hindered by the challenge of delivering large chromatin regulators. Here, we develop a new method for generating small nanobodies against human chromatin regulators that can repress or activate gene expression. We start with a large and diverse nanobody library and perform enrichment against chromatin regulatory complexes using yeast display, followed by high-throughput pooled selection for transcriptional control when recruited to a reporter in human cells. This workflow allows us to efficiently select tens of functional nanobodies that can act as transcriptional repressors or activators in human cells.
Competing Interests: Competing Interest Statement J.W. and L.B. have submitted a provisional patent application related to this work. L.B. is a co-founder of Stylus Medicine and a member of its scientific advisory board. All other authors declare they have no known competing interests.